nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvastatin—CYP3A4—bone cancer	0.407	1	CbGaD
Fluvastatin—UGT2B7—Epirubicin—bone cancer	0.157	0.391	CbGbCtD
Fluvastatin—SLCO1B3—Methotrexate—bone cancer	0.0832	0.207	CbGbCtD
Fluvastatin—SLCO1B1—Methotrexate—bone cancer	0.0485	0.12	CbGbCtD
Fluvastatin—CYP2B6—Cisplatin—bone cancer	0.0417	0.104	CbGbCtD
Fluvastatin—CYP2B6—Doxorubicin—bone cancer	0.028	0.0694	CbGbCtD
Fluvastatin—CYP2C9—Cisplatin—bone cancer	0.022	0.0547	CbGbCtD
Fluvastatin—CYP2D6—Doxorubicin—bone cancer	0.0135	0.0335	CbGbCtD
Fluvastatin—CYP3A4—Doxorubicin—bone cancer	0.00859	0.0213	CbGbCtD
Fluvastatin—Rosuvastatin—CYP3A4—bone cancer	0.00151	0.587	CrCbGaD
Fluvastatin—Atorvastatin—CYP3A4—bone cancer	0.00107	0.413	CrCbGaD
Fluvastatin—Upper respiratory tract infection—Methotrexate—bone cancer	0.00029	0.00282	CcSEcCtD
Fluvastatin—CYP1A1—Tryptophan metabolism—CYP3A4—bone cancer	0.00029	0.00343	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.000289	0.00343	CbGpPWpGaD
Fluvastatin—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000289	0.00342	CbGpPWpGaD
Fluvastatin—Eosinophilia—Epirubicin—bone cancer	0.000289	0.00281	CcSEcCtD
Fluvastatin—Dyspnoea—Cisplatin—bone cancer	0.000288	0.0028	CcSEcCtD
Fluvastatin—Erectile dysfunction—Methotrexate—bone cancer	0.000287	0.00279	CcSEcCtD
Fluvastatin—Pancreatitis—Epirubicin—bone cancer	0.000286	0.00278	CcSEcCtD
Fluvastatin—Abdominal pain upper—Doxorubicin—bone cancer	0.000286	0.00277	CcSEcCtD
Fluvastatin—Photosensitivity reaction—Methotrexate—bone cancer	0.000285	0.00277	CcSEcCtD
Fluvastatin—Breast disorder—Doxorubicin—bone cancer	0.000283	0.00274	CcSEcCtD
Fluvastatin—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000282	0.00273	CcSEcCtD
Fluvastatin—Decreased appetite—Cisplatin—bone cancer	0.000281	0.00273	CcSEcCtD
Fluvastatin—Bronchitis—Epirubicin—bone cancer	0.000281	0.00273	CcSEcCtD
Fluvastatin—Nasopharyngitis—Doxorubicin—bone cancer	0.00028	0.00272	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Cisplatin—bone cancer	0.000279	0.00271	CcSEcCtD
Fluvastatin—Infestation NOS—Methotrexate—bone cancer	0.000278	0.0027	CcSEcCtD
Fluvastatin—Infestation—Methotrexate—bone cancer	0.000278	0.0027	CcSEcCtD
Fluvastatin—Gastritis—Doxorubicin—bone cancer	0.000277	0.00269	CcSEcCtD
Fluvastatin—Pain—Cisplatin—bone cancer	0.000277	0.00269	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000276	0.00268	CcSEcCtD
Fluvastatin—Muscular weakness—Doxorubicin—bone cancer	0.000276	0.00268	CcSEcCtD
Fluvastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000275	0.00326	CbGpPWpGaD
Fluvastatin—Upper respiratory tract infection—Epirubicin—bone cancer	0.000271	0.00264	CcSEcCtD
Fluvastatin—Conjunctivitis—Methotrexate—bone cancer	0.00027	0.00263	CcSEcCtD
Fluvastatin—Influenza—Doxorubicin—bone cancer	0.00027	0.00262	CcSEcCtD
Fluvastatin—Eosinophilia—Doxorubicin—bone cancer	0.000268	0.0026	CcSEcCtD
Fluvastatin—Sweating—Methotrexate—bone cancer	0.000267	0.00259	CcSEcCtD
Fluvastatin—Photosensitivity reaction—Epirubicin—bone cancer	0.000267	0.00259	CcSEcCtD
Fluvastatin—Feeling abnormal—Cisplatin—bone cancer	0.000266	0.00259	CcSEcCtD
Fluvastatin—Pancreatitis—Doxorubicin—bone cancer	0.000265	0.00257	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Methotrexate—bone cancer	0.000263	0.00256	CcSEcCtD
Fluvastatin—Infestation—Epirubicin—bone cancer	0.00026	0.00253	CcSEcCtD
Fluvastatin—Infestation NOS—Epirubicin—bone cancer	0.00026	0.00253	CcSEcCtD
Fluvastatin—Bronchitis—Doxorubicin—bone cancer	0.00026	0.00252	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000258	0.00251	CcSEcCtD
Fluvastatin—UGT1A1—Phase II conjugation—GSTP1—bone cancer	0.000257	0.00304	CbGpPWpGaD
Fluvastatin—Body temperature increased—Cisplatin—bone cancer	0.000256	0.00248	CcSEcCtD
Fluvastatin—Neuropathy peripheral—Epirubicin—bone cancer	0.000255	0.00248	CcSEcCtD
Fluvastatin—UGT1A3—Biological oxidations—CYP3A4—bone cancer	0.000254	0.00301	CbGpPWpGaD
Fluvastatin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000254	0.00301	CbGpPWpGaD
Fluvastatin—Conjunctivitis—Epirubicin—bone cancer	0.000253	0.00246	CcSEcCtD
Fluvastatin—Urinary tract infection—Epirubicin—bone cancer	0.000253	0.00246	CcSEcCtD
Fluvastatin—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000251	0.00244	CcSEcCtD
Fluvastatin—UGT1A3—Metapathway biotransformation—CYP3A4—bone cancer	0.000251	0.00297	CbGpPWpGaD
Fluvastatin—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00025	0.00297	CbGpPWpGaD
Fluvastatin—Hepatitis—Methotrexate—bone cancer	0.00025	0.00243	CcSEcCtD
Fluvastatin—Sweating—Epirubicin—bone cancer	0.00025	0.00242	CcSEcCtD
Fluvastatin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000248	0.00294	CbGpPWpGaD
Fluvastatin—UGT1A3—NRF2 pathway—GSTP1—bone cancer	0.000248	0.00294	CbGpPWpGaD
Fluvastatin—UGT1A3—NRF2 pathway—TGFBR2—bone cancer	0.000248	0.00294	CbGpPWpGaD
Fluvastatin—Pharyngitis—Methotrexate—bone cancer	0.000248	0.00241	CcSEcCtD
Fluvastatin—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000248	0.00293	CbGpPWpGaD
Fluvastatin—Photosensitivity reaction—Doxorubicin—bone cancer	0.000247	0.0024	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Epirubicin—bone cancer	0.000246	0.00239	CcSEcCtD
Fluvastatin—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000245	0.0029	CbGpPWpGaD
Fluvastatin—Sinusitis—Epirubicin—bone cancer	0.000244	0.00237	CcSEcCtD
Fluvastatin—Infestation NOS—Doxorubicin—bone cancer	0.000241	0.00234	CcSEcCtD
Fluvastatin—Infestation—Doxorubicin—bone cancer	0.000241	0.00234	CcSEcCtD
Fluvastatin—Visual impairment—Methotrexate—bone cancer	0.000241	0.00234	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000239	0.00232	CcSEcCtD
Fluvastatin—Hypersensitivity—Cisplatin—bone cancer	0.000238	0.00231	CcSEcCtD
Fluvastatin—Erythema multiforme—Methotrexate—bone cancer	0.000236	0.00229	CcSEcCtD
Fluvastatin—Neuropathy peripheral—Doxorubicin—bone cancer	0.000236	0.00229	CcSEcCtD
Fluvastatin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000235	0.00279	CbGpPWpGaD
Fluvastatin—SLCO2B1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000235	0.00279	CbGpPWpGaD
Fluvastatin—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000234	0.00278	CbGpPWpGaD
Fluvastatin—Rhinitis—Epirubicin—bone cancer	0.000234	0.00228	CcSEcCtD
Fluvastatin—Urinary tract infection—Doxorubicin—bone cancer	0.000234	0.00227	CcSEcCtD
Fluvastatin—Conjunctivitis—Doxorubicin—bone cancer	0.000234	0.00227	CcSEcCtD
Fluvastatin—Hepatitis—Epirubicin—bone cancer	0.000234	0.00227	CcSEcCtD
Fluvastatin—Hypoaesthesia—Epirubicin—bone cancer	0.000233	0.00226	CcSEcCtD
Fluvastatin—Asthenia—Cisplatin—bone cancer	0.000232	0.00225	CcSEcCtD
Fluvastatin—Pharyngitis—Epirubicin—bone cancer	0.000232	0.00225	CcSEcCtD
Fluvastatin—Cardiac disorder—Methotrexate—bone cancer	0.000232	0.00225	CcSEcCtD
Fluvastatin—CYP1A1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000231	0.00274	CbGpPWpGaD
Fluvastatin—Sweating—Doxorubicin—bone cancer	0.000231	0.00224	CcSEcCtD
Fluvastatin—Oedema peripheral—Epirubicin—bone cancer	0.00023	0.00224	CcSEcCtD
Fluvastatin—Connective tissue disorder—Epirubicin—bone cancer	0.00023	0.00223	CcSEcCtD
Fluvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000229	0.00272	CbGpPWpGaD
Fluvastatin—Hepatobiliary disease—Doxorubicin—bone cancer	0.000228	0.00221	CcSEcCtD
Fluvastatin—Angiopathy—Methotrexate—bone cancer	0.000227	0.0022	CcSEcCtD
Fluvastatin—Sinusitis—Doxorubicin—bone cancer	0.000226	0.0022	CcSEcCtD
Fluvastatin—Immune system disorder—Methotrexate—bone cancer	0.000226	0.00219	CcSEcCtD
Fluvastatin—Visual impairment—Epirubicin—bone cancer	0.000225	0.00219	CcSEcCtD
Fluvastatin—Chills—Methotrexate—bone cancer	0.000224	0.00218	CcSEcCtD
Fluvastatin—Diarrhoea—Cisplatin—bone cancer	0.000221	0.00215	CcSEcCtD
Fluvastatin—Erythema multiforme—Epirubicin—bone cancer	0.000221	0.00215	CcSEcCtD
Fluvastatin—Alopecia—Methotrexate—bone cancer	0.000221	0.00214	CcSEcCtD
Fluvastatin—Mental disorder—Methotrexate—bone cancer	0.000219	0.00213	CcSEcCtD
Fluvastatin—UGT1A3—Biological oxidations—GSTP1—bone cancer	0.000218	0.00258	CbGpPWpGaD
Fluvastatin—Erythema—Methotrexate—bone cancer	0.000217	0.00211	CcSEcCtD
Fluvastatin—Flushing—Epirubicin—bone cancer	0.000217	0.00211	CcSEcCtD
Fluvastatin—Cardiac disorder—Epirubicin—bone cancer	0.000217	0.00211	CcSEcCtD
Fluvastatin—Rhinitis—Doxorubicin—bone cancer	0.000217	0.00211	CcSEcCtD
Fluvastatin—Hepatitis—Doxorubicin—bone cancer	0.000216	0.0021	CcSEcCtD
Fluvastatin—UGT2B7—Biological oxidations—CYP3A4—bone cancer	0.000216	0.00256	CbGpPWpGaD
Fluvastatin—Hypoaesthesia—Doxorubicin—bone cancer	0.000215	0.00209	CcSEcCtD
Fluvastatin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000215	0.00254	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.000215	0.00254	CbGpPWpGaD
Fluvastatin—Pharyngitis—Doxorubicin—bone cancer	0.000215	0.00208	CcSEcCtD
Fluvastatin—UGT1A3—Metapathway biotransformation—GSTP1—bone cancer	0.000215	0.00254	CbGpPWpGaD
Fluvastatin—UGT2B7—Metapathway biotransformation—CYP3A4—bone cancer	0.000213	0.00253	CbGpPWpGaD
Fluvastatin—Oedema peripheral—Doxorubicin—bone cancer	0.000213	0.00207	CcSEcCtD
Fluvastatin—Dysgeusia—Methotrexate—bone cancer	0.000213	0.00207	CcSEcCtD
Fluvastatin—Connective tissue disorder—Doxorubicin—bone cancer	0.000213	0.00206	CcSEcCtD
Fluvastatin—Angiopathy—Epirubicin—bone cancer	0.000212	0.00206	CcSEcCtD
Fluvastatin—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000212	0.00251	CbGpPWpGaD
Fluvastatin—Immune system disorder—Epirubicin—bone cancer	0.000211	0.00205	CcSEcCtD
Fluvastatin—UGT2B7—NRF2 pathway—TGFBR2—bone cancer	0.000211	0.0025	CbGpPWpGaD
Fluvastatin—UGT2B7—NRF2 pathway—GSTP1—bone cancer	0.000211	0.0025	CbGpPWpGaD
Fluvastatin—Back pain—Methotrexate—bone cancer	0.00021	0.00204	CcSEcCtD
Fluvastatin—Chills—Epirubicin—bone cancer	0.00021	0.00204	CcSEcCtD
Fluvastatin—Arrhythmia—Epirubicin—bone cancer	0.000209	0.00203	CcSEcCtD
Fluvastatin—Visual impairment—Doxorubicin—bone cancer	0.000208	0.00202	CcSEcCtD
Fluvastatin—Alopecia—Epirubicin—bone cancer	0.000207	0.00201	CcSEcCtD
Fluvastatin—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000206	0.00244	CbGpPWpGaD
Fluvastatin—Vomiting—Cisplatin—bone cancer	0.000206	0.002	CcSEcCtD
Fluvastatin—Mental disorder—Epirubicin—bone cancer	0.000205	0.00199	CcSEcCtD
Fluvastatin—Erythema multiforme—Doxorubicin—bone cancer	0.000204	0.00199	CcSEcCtD
Fluvastatin—Rash—Cisplatin—bone cancer	0.000204	0.00198	CcSEcCtD
Fluvastatin—Dermatitis—Cisplatin—bone cancer	0.000204	0.00198	CcSEcCtD
Fluvastatin—Erythema—Epirubicin—bone cancer	0.000203	0.00198	CcSEcCtD
Fluvastatin—SLCO2B1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000203	0.00241	CbGpPWpGaD
Fluvastatin—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000203	0.0024	CbGpPWpGaD
Fluvastatin—Ill-defined disorder—Methotrexate—bone cancer	0.000202	0.00196	CcSEcCtD
Fluvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000202	0.00239	CbGpPWpGaD
Fluvastatin—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000201	0.00238	CbGpPWpGaD
Fluvastatin—Cardiac disorder—Doxorubicin—bone cancer	0.000201	0.00195	CcSEcCtD
Fluvastatin—Flushing—Doxorubicin—bone cancer	0.000201	0.00195	CcSEcCtD
Fluvastatin—Flatulence—Epirubicin—bone cancer	0.0002	0.00195	CcSEcCtD
Fluvastatin—Dysgeusia—Epirubicin—bone cancer	0.000199	0.00194	CcSEcCtD
Fluvastatin—Back pain—Epirubicin—bone cancer	0.000197	0.00191	CcSEcCtD
Fluvastatin—Angiopathy—Doxorubicin—bone cancer	0.000196	0.00191	CcSEcCtD
Fluvastatin—Malaise—Methotrexate—bone cancer	0.000196	0.0019	CcSEcCtD
Fluvastatin—Muscle spasms—Epirubicin—bone cancer	0.000196	0.0019	CcSEcCtD
Fluvastatin—Immune system disorder—Doxorubicin—bone cancer	0.000195	0.0019	CcSEcCtD
Fluvastatin—Vertigo—Methotrexate—bone cancer	0.000195	0.0019	CcSEcCtD
Fluvastatin—Leukopenia—Methotrexate—bone cancer	0.000195	0.00189	CcSEcCtD
Fluvastatin—Chills—Doxorubicin—bone cancer	0.000194	0.00188	CcSEcCtD
Fluvastatin—Arrhythmia—Doxorubicin—bone cancer	0.000193	0.00188	CcSEcCtD
Fluvastatin—Nausea—Cisplatin—bone cancer	0.000192	0.00187	CcSEcCtD
Fluvastatin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000192	0.00227	CbGpPWpGaD
Fluvastatin—Alopecia—Doxorubicin—bone cancer	0.000191	0.00186	CcSEcCtD
Fluvastatin—CYP1A1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00019	0.00225	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.00019	0.00225	CbGpPWpGaD
Fluvastatin—Cough—Methotrexate—bone cancer	0.00019	0.00184	CcSEcCtD
Fluvastatin—Mental disorder—Doxorubicin—bone cancer	0.000189	0.00184	CcSEcCtD
Fluvastatin—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000189	0.00224	CbGpPWpGaD
Fluvastatin—Ill-defined disorder—Epirubicin—bone cancer	0.000189	0.00183	CcSEcCtD
Fluvastatin—Erythema—Doxorubicin—bone cancer	0.000188	0.00183	CcSEcCtD
Fluvastatin—HMGCR—Metabolism—NDUFA12—bone cancer	0.000187	0.00221	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—RB1—bone cancer	0.000187	0.00221	CbGpPWpGaD
Fluvastatin—Flatulence—Doxorubicin—bone cancer	0.000186	0.0018	CcSEcCtD
Fluvastatin—Arthralgia—Methotrexate—bone cancer	0.000185	0.0018	CcSEcCtD
Fluvastatin—Chest pain—Methotrexate—bone cancer	0.000185	0.0018	CcSEcCtD
Fluvastatin—Myalgia—Methotrexate—bone cancer	0.000185	0.0018	CcSEcCtD
Fluvastatin—UGT2B7—Biological oxidations—GSTP1—bone cancer	0.000185	0.00219	CbGpPWpGaD
Fluvastatin—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000185	0.00219	CbGpPWpGaD
Fluvastatin—Dysgeusia—Doxorubicin—bone cancer	0.000184	0.00179	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000184	0.00179	CcSEcCtD
Fluvastatin—SLCO1B3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000184	0.00218	CbGpPWpGaD
Fluvastatin—Malaise—Epirubicin—bone cancer	0.000183	0.00178	CcSEcCtD
Fluvastatin—Discomfort—Methotrexate—bone cancer	0.000183	0.00178	CcSEcCtD
Fluvastatin—SLC15A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000183	0.00216	CbGpPWpGaD
Fluvastatin—Vertigo—Epirubicin—bone cancer	0.000183	0.00178	CcSEcCtD
Fluvastatin—Syncope—Epirubicin—bone cancer	0.000182	0.00177	CcSEcCtD
Fluvastatin—UGT2B7—Metapathway biotransformation—GSTP1—bone cancer	0.000182	0.00216	CbGpPWpGaD
Fluvastatin—Leukopenia—Epirubicin—bone cancer	0.000182	0.00177	CcSEcCtD
Fluvastatin—Back pain—Doxorubicin—bone cancer	0.000182	0.00177	CcSEcCtD
Fluvastatin—Muscle spasms—Doxorubicin—bone cancer	0.000181	0.00176	CcSEcCtD
Fluvastatin—Confusional state—Methotrexate—bone cancer	0.000179	0.00174	CcSEcCtD
Fluvastatin—Loss of consciousness—Epirubicin—bone cancer	0.000179	0.00174	CcSEcCtD
Fluvastatin—Cough—Epirubicin—bone cancer	0.000178	0.00172	CcSEcCtD
Fluvastatin—Anaphylactic shock—Methotrexate—bone cancer	0.000177	0.00172	CcSEcCtD
Fluvastatin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000176	0.00209	CbGpPWpGaD
Fluvastatin—Infection—Methotrexate—bone cancer	0.000176	0.00171	CcSEcCtD
Fluvastatin—UGT1A1—Biological oxidations—CYP3A4—bone cancer	0.000176	0.00208	CbGpPWpGaD
Fluvastatin—Hypertension—Epirubicin—bone cancer	0.000176	0.00171	CcSEcCtD
Fluvastatin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000175	0.00207	CbGpPWpGaD
Fluvastatin—Ill-defined disorder—Doxorubicin—bone cancer	0.000175	0.0017	CcSEcCtD
Fluvastatin—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000174	0.00206	CbGpPWpGaD
Fluvastatin—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000174	0.00206	CbGpPWpGaD
Fluvastatin—Nervous system disorder—Methotrexate—bone cancer	0.000174	0.00169	CcSEcCtD
Fluvastatin—Thrombocytopenia—Methotrexate—bone cancer	0.000174	0.00169	CcSEcCtD
Fluvastatin—UGT1A1—Metapathway biotransformation—CYP3A4—bone cancer	0.000173	0.00205	CbGpPWpGaD
Fluvastatin—Myalgia—Epirubicin—bone cancer	0.000173	0.00168	CcSEcCtD
Fluvastatin—Chest pain—Epirubicin—bone cancer	0.000173	0.00168	CcSEcCtD
Fluvastatin—Arthralgia—Epirubicin—bone cancer	0.000173	0.00168	CcSEcCtD
Fluvastatin—Anxiety—Epirubicin—bone cancer	0.000173	0.00168	CcSEcCtD
Fluvastatin—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000173	0.00204	CbGpPWpGaD
Fluvastatin—Skin disorder—Methotrexate—bone cancer	0.000172	0.00167	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000172	0.00167	CcSEcCtD
Fluvastatin—Hyperhidrosis—Methotrexate—bone cancer	0.000172	0.00167	CcSEcCtD
Fluvastatin—UGT1A1—NRF2 pathway—TGFBR2—bone cancer	0.000171	0.00203	CbGpPWpGaD
Fluvastatin—UGT1A1—NRF2 pathway—GSTP1—bone cancer	0.000171	0.00203	CbGpPWpGaD
Fluvastatin—Discomfort—Epirubicin—bone cancer	0.000171	0.00166	CcSEcCtD
Fluvastatin—HMGCR—AMPK Signaling—TP53—bone cancer	0.000171	0.00202	CbGpPWpGaD
Fluvastatin—Malaise—Doxorubicin—bone cancer	0.00017	0.00165	CcSEcCtD
Fluvastatin—Vertigo—Doxorubicin—bone cancer	0.000169	0.00164	CcSEcCtD
Fluvastatin—Anorexia—Methotrexate—bone cancer	0.000169	0.00164	CcSEcCtD
Fluvastatin—Syncope—Doxorubicin—bone cancer	0.000169	0.00164	CcSEcCtD
Fluvastatin—Leukopenia—Doxorubicin—bone cancer	0.000169	0.00164	CcSEcCtD
Fluvastatin—Confusional state—Epirubicin—bone cancer	0.000167	0.00163	CcSEcCtD
Fluvastatin—Anaphylactic shock—Epirubicin—bone cancer	0.000166	0.00161	CcSEcCtD
Fluvastatin—Loss of consciousness—Doxorubicin—bone cancer	0.000165	0.00161	CcSEcCtD
Fluvastatin—Infection—Epirubicin—bone cancer	0.000165	0.0016	CcSEcCtD
Fluvastatin—Cough—Doxorubicin—bone cancer	0.000164	0.0016	CcSEcCtD
Fluvastatin—Shock—Epirubicin—bone cancer	0.000163	0.00159	CcSEcCtD
Fluvastatin—Nervous system disorder—Epirubicin—bone cancer	0.000163	0.00158	CcSEcCtD
Fluvastatin—Thrombocytopenia—Epirubicin—bone cancer	0.000163	0.00158	CcSEcCtD
Fluvastatin—Hypertension—Doxorubicin—bone cancer	0.000163	0.00158	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000162	0.00157	CcSEcCtD
Fluvastatin—Skin disorder—Epirubicin—bone cancer	0.000161	0.00157	CcSEcCtD
Fluvastatin—Hyperhidrosis—Epirubicin—bone cancer	0.000161	0.00156	CcSEcCtD
Fluvastatin—Insomnia—Methotrexate—bone cancer	0.00016	0.00156	CcSEcCtD
Fluvastatin—Arthralgia—Doxorubicin—bone cancer	0.00016	0.00156	CcSEcCtD
Fluvastatin—Chest pain—Doxorubicin—bone cancer	0.00016	0.00156	CcSEcCtD
Fluvastatin—Myalgia—Doxorubicin—bone cancer	0.00016	0.00156	CcSEcCtD
Fluvastatin—Anxiety—Doxorubicin—bone cancer	0.00016	0.00155	CcSEcCtD
Fluvastatin—Paraesthesia—Methotrexate—bone cancer	0.000159	0.00155	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000159	0.00155	CcSEcCtD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.000159	0.00188	CbGpPWpGaD
Fluvastatin—SLCO1B3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000159	0.00188	CbGpPWpGaD
Fluvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000159	0.00188	CbGpPWpGaD
Fluvastatin—Discomfort—Doxorubicin—bone cancer	0.000158	0.00154	CcSEcCtD
Fluvastatin—Anorexia—Epirubicin—bone cancer	0.000158	0.00154	CcSEcCtD
Fluvastatin—Dyspnoea—Methotrexate—bone cancer	0.000158	0.00154	CcSEcCtD
Fluvastatin—SLC15A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000158	0.00187	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000156	0.00185	CbGpPWpGaD
Fluvastatin—Dyspepsia—Methotrexate—bone cancer	0.000156	0.00152	CcSEcCtD
Fluvastatin—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000155	0.00184	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—NT5C3A—bone cancer	0.000155	0.00183	CbGpPWpGaD
Fluvastatin—Confusional state—Doxorubicin—bone cancer	0.000155	0.0015	CcSEcCtD
Fluvastatin—Decreased appetite—Methotrexate—bone cancer	0.000154	0.0015	CcSEcCtD
Fluvastatin—Anaphylactic shock—Doxorubicin—bone cancer	0.000154	0.00149	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Methotrexate—bone cancer	0.000153	0.00149	CcSEcCtD
Fluvastatin—Fatigue—Methotrexate—bone cancer	0.000153	0.00149	CcSEcCtD
Fluvastatin—Infection—Doxorubicin—bone cancer	0.000153	0.00148	CcSEcCtD
Fluvastatin—UGT1A3—Metabolism—NDUFA12—bone cancer	0.000152	0.0018	CbGpPWpGaD
Fluvastatin—Pain—Methotrexate—bone cancer	0.000152	0.00147	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000151	0.00147	CcSEcCtD
Fluvastatin—Shock—Doxorubicin—bone cancer	0.000151	0.00147	CcSEcCtD
Fluvastatin—Nervous system disorder—Doxorubicin—bone cancer	0.000151	0.00146	CcSEcCtD
Fluvastatin—Thrombocytopenia—Doxorubicin—bone cancer	0.00015	0.00146	CcSEcCtD
Fluvastatin—UGT1A1—Biological oxidations—GSTP1—bone cancer	0.00015	0.00178	CbGpPWpGaD
Fluvastatin—Insomnia—Epirubicin—bone cancer	0.00015	0.00146	CcSEcCtD
Fluvastatin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000149	0.00177	CbGpPWpGaD
Fluvastatin—Skin disorder—Doxorubicin—bone cancer	0.000149	0.00145	CcSEcCtD
Fluvastatin—Paraesthesia—Epirubicin—bone cancer	0.000149	0.00145	CcSEcCtD
Fluvastatin—Hyperhidrosis—Doxorubicin—bone cancer	0.000149	0.00144	CcSEcCtD
Fluvastatin—UGT1A1—Metapathway biotransformation—GSTP1—bone cancer	0.000148	0.00176	CbGpPWpGaD
Fluvastatin—Dyspnoea—Epirubicin—bone cancer	0.000148	0.00144	CcSEcCtD
Fluvastatin—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000147	0.00175	CbGpPWpGaD
Fluvastatin—Anorexia—Doxorubicin—bone cancer	0.000146	0.00142	CcSEcCtD
Fluvastatin—Feeling abnormal—Methotrexate—bone cancer	0.000146	0.00142	CcSEcCtD
Fluvastatin—Dyspepsia—Epirubicin—bone cancer	0.000146	0.00142	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Methotrexate—bone cancer	0.000145	0.00141	CcSEcCtD
Fluvastatin—Decreased appetite—Epirubicin—bone cancer	0.000144	0.0014	CcSEcCtD
Fluvastatin—SLCO1B3—Metabolism—NDUFA12—bone cancer	0.000144	0.0017	CbGpPWpGaD
Fluvastatin—Gastrointestinal disorder—Epirubicin—bone cancer	0.000143	0.00139	CcSEcCtD
Fluvastatin—Fatigue—Epirubicin—bone cancer	0.000143	0.00139	CcSEcCtD
Fluvastatin—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000143	0.00169	CbGpPWpGaD
Fluvastatin—Pain—Epirubicin—bone cancer	0.000142	0.00138	CcSEcCtD
Fluvastatin—Constipation—Epirubicin—bone cancer	0.000142	0.00138	CcSEcCtD
Fluvastatin—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000142	0.00168	CbGpPWpGaD
Fluvastatin—Urticaria—Methotrexate—bone cancer	0.000141	0.00137	CcSEcCtD
Fluvastatin—Abdominal pain—Methotrexate—bone cancer	0.00014	0.00136	CcSEcCtD
Fluvastatin—Body temperature increased—Methotrexate—bone cancer	0.00014	0.00136	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00014	0.00136	CcSEcCtD
Fluvastatin—Insomnia—Doxorubicin—bone cancer	0.000139	0.00135	CcSEcCtD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—JUN—bone cancer	0.000138	0.00164	CbGpPWpGaD
Fluvastatin—Paraesthesia—Doxorubicin—bone cancer	0.000138	0.00134	CcSEcCtD
Fluvastatin—Dyspnoea—Doxorubicin—bone cancer	0.000137	0.00133	CcSEcCtD
Fluvastatin—Feeling abnormal—Epirubicin—bone cancer	0.000137	0.00133	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Epirubicin—bone cancer	0.000136	0.00132	CcSEcCtD
Fluvastatin—Dyspepsia—Doxorubicin—bone cancer	0.000135	0.00131	CcSEcCtD
Fluvastatin—Decreased appetite—Doxorubicin—bone cancer	0.000134	0.0013	CcSEcCtD
Fluvastatin—CYP1A1—Tryptophan metabolism—MDM2—bone cancer	0.000133	0.00158	CbGpPWpGaD
Fluvastatin—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000133	0.00129	CcSEcCtD
Fluvastatin—Fatigue—Doxorubicin—bone cancer	0.000132	0.00129	CcSEcCtD
Fluvastatin—Urticaria—Epirubicin—bone cancer	0.000132	0.00128	CcSEcCtD
Fluvastatin—Constipation—Doxorubicin—bone cancer	0.000131	0.00128	CcSEcCtD
Fluvastatin—Pain—Doxorubicin—bone cancer	0.000131	0.00128	CcSEcCtD
Fluvastatin—Body temperature increased—Epirubicin—bone cancer	0.000131	0.00127	CcSEcCtD
Fluvastatin—Abdominal pain—Epirubicin—bone cancer	0.000131	0.00127	CcSEcCtD
Fluvastatin—Hypersensitivity—Methotrexate—bone cancer	0.000131	0.00127	CcSEcCtD
Fluvastatin—UGT2B7—Metabolism—NDUFA12—bone cancer	0.00013	0.00153	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000128	0.00152	CbGpPWpGaD
Fluvastatin—Asthenia—Methotrexate—bone cancer	0.000127	0.00124	CcSEcCtD
Fluvastatin—Feeling abnormal—Doxorubicin—bone cancer	0.000127	0.00123	CcSEcCtD
Fluvastatin—UGT1A3—Metabolism—NT5C3A—bone cancer	0.000126	0.0015	CbGpPWpGaD
Fluvastatin—Gastrointestinal pain—Doxorubicin—bone cancer	0.000126	0.00122	CcSEcCtD
Fluvastatin—Pruritus—Methotrexate—bone cancer	0.000126	0.00122	CcSEcCtD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000123	0.00146	CbGpPWpGaD
Fluvastatin—Hypersensitivity—Epirubicin—bone cancer	0.000122	0.00119	CcSEcCtD
Fluvastatin—Urticaria—Doxorubicin—bone cancer	0.000122	0.00119	CcSEcCtD
Fluvastatin—Abdominal pain—Doxorubicin—bone cancer	0.000121	0.00118	CcSEcCtD
Fluvastatin—Body temperature increased—Doxorubicin—bone cancer	0.000121	0.00118	CcSEcCtD
Fluvastatin—Diarrhoea—Methotrexate—bone cancer	0.000121	0.00118	CcSEcCtD
Fluvastatin—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000121	0.00143	CbGpPWpGaD
Fluvastatin—CYP1A1—Arachidonic acid metabolism—PTGS2—bone cancer	0.00012	0.00142	CbGpPWpGaD
Fluvastatin—Asthenia—Epirubicin—bone cancer	0.000119	0.00116	CcSEcCtD
Fluvastatin—SLCO1B3—Metabolism—NT5C3A—bone cancer	0.000119	0.00141	CbGpPWpGaD
Fluvastatin—Pruritus—Epirubicin—bone cancer	0.000117	0.00114	CcSEcCtD
Fluvastatin—Dizziness—Methotrexate—bone cancer	0.000117	0.00114	CcSEcCtD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000116	0.00137	CbGpPWpGaD
Fluvastatin—Diarrhoea—Epirubicin—bone cancer	0.000114	0.0011	CcSEcCtD
Fluvastatin—Hypersensitivity—Doxorubicin—bone cancer	0.000113	0.0011	CcSEcCtD
Fluvastatin—Vomiting—Methotrexate—bone cancer	0.000113	0.0011	CcSEcCtD
Fluvastatin—Rash—Methotrexate—bone cancer	0.000112	0.00109	CcSEcCtD
Fluvastatin—Dermatitis—Methotrexate—bone cancer	0.000112	0.00109	CcSEcCtD
Fluvastatin—Headache—Methotrexate—bone cancer	0.000111	0.00108	CcSEcCtD
Fluvastatin—Asthenia—Doxorubicin—bone cancer	0.00011	0.00107	CcSEcCtD
Fluvastatin—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.00011	0.0013	CbGpPWpGaD
Fluvastatin—Dizziness—Epirubicin—bone cancer	0.00011	0.00107	CcSEcCtD
Fluvastatin—CYP2B6—Biological oxidations—CYP3A4—bone cancer	0.000109	0.00129	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—EGFR—bone cancer	0.000109	0.00129	CbGpPWpGaD
Fluvastatin—Pruritus—Doxorubicin—bone cancer	0.000109	0.00106	CcSEcCtD
Fluvastatin—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	0.000108	0.00128	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—NT5C3A—bone cancer	0.000107	0.00127	CbGpPWpGaD
Fluvastatin—CYP3A5—Biological oxidations—CYP3A4—bone cancer	0.000107	0.00126	CbGpPWpGaD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000107	0.00126	CbGpPWpGaD
Fluvastatin—Vomiting—Epirubicin—bone cancer	0.000106	0.00103	CcSEcCtD
Fluvastatin—Nausea—Methotrexate—bone cancer	0.000105	0.00102	CcSEcCtD
Fluvastatin—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	0.000105	0.00125	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—NDUFA12—bone cancer	0.000105	0.00125	CbGpPWpGaD
Fluvastatin—Diarrhoea—Doxorubicin—bone cancer	0.000105	0.00102	CcSEcCtD
Fluvastatin—Rash—Epirubicin—bone cancer	0.000105	0.00102	CcSEcCtD
Fluvastatin—Dermatitis—Epirubicin—bone cancer	0.000105	0.00102	CcSEcCtD
Fluvastatin—Headache—Epirubicin—bone cancer	0.000104	0.00101	CcSEcCtD
Fluvastatin—Dizziness—Doxorubicin—bone cancer	0.000102	0.000987	CcSEcCtD
Fluvastatin—CYP1A1—Biological oxidations—CYP3A4—bone cancer	0.000101	0.00119	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	9.96e-05	0.00118	CbGpPWpGaD
Fluvastatin—CYP1A1—Metapathway biotransformation—CYP3A4—bone cancer	9.95e-05	0.00118	CbGpPWpGaD
Fluvastatin—Nausea—Epirubicin—bone cancer	9.86e-05	0.000958	CcSEcCtD
Fluvastatin—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	9.83e-05	0.00116	CbGpPWpGaD
Fluvastatin—Vomiting—Doxorubicin—bone cancer	9.77e-05	0.000949	CcSEcCtD
Fluvastatin—Rash—Doxorubicin—bone cancer	9.69e-05	0.000941	CcSEcCtD
Fluvastatin—Dermatitis—Doxorubicin—bone cancer	9.68e-05	0.00094	CcSEcCtD
Fluvastatin—SLCO1B1—Metabolism—NDUFA12—bone cancer	9.65e-05	0.00114	CbGpPWpGaD
Fluvastatin—Headache—Doxorubicin—bone cancer	9.63e-05	0.000935	CcSEcCtD
Fluvastatin—CYP1A2—Phase II conjugation—GSTP1—bone cancer	9.41e-05	0.00111	CbGpPWpGaD
Fluvastatin—CYP2B6—Biological oxidations—GSTP1—bone cancer	9.35e-05	0.00111	CbGpPWpGaD
Fluvastatin—CYP2C8—Biological oxidations—CYP3A4—bone cancer	9.25e-05	0.0011	CbGpPWpGaD
Fluvastatin—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	9.22e-05	0.00109	CbGpPWpGaD
Fluvastatin—CYP3A5—Biological oxidations—GSTP1—bone cancer	9.14e-05	0.00108	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—bone cancer	9.13e-05	0.00108	CbGpPWpGaD
Fluvastatin—Nausea—Doxorubicin—bone cancer	9.13e-05	0.000886	CcSEcCtD
Fluvastatin—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	9.13e-05	0.00108	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	9.11e-05	0.00108	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	9.11e-05	0.00108	CbGpPWpGaD
Fluvastatin—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	9.01e-05	0.00107	CbGpPWpGaD
Fluvastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	8.97e-05	0.00106	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—NT5C3A—bone cancer	8.73e-05	0.00103	CbGpPWpGaD
Fluvastatin—CYP1A1—Biological oxidations—GSTP1—bone cancer	8.63e-05	0.00102	CbGpPWpGaD
Fluvastatin—CYP1A1—Metapathway biotransformation—GSTP1—bone cancer	8.51e-05	0.00101	CbGpPWpGaD
Fluvastatin—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	8.5e-05	0.00101	CbGpPWpGaD
Fluvastatin—CYP2C19—Biological oxidations—CYP3A4—bone cancer	8.26e-05	0.000978	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	8.19e-05	0.00097	CbGpPWpGaD
Fluvastatin—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	8.15e-05	0.000964	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—NT5C3A—bone cancer	8e-05	0.000947	CbGpPWpGaD
Fluvastatin—CYP2C8—Biological oxidations—GSTP1—bone cancer	7.91e-05	0.000937	CbGpPWpGaD
Fluvastatin—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	7.81e-05	0.000924	CbGpPWpGaD
Fluvastatin—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	7.66e-05	0.000907	CbGpPWpGaD
Fluvastatin—CYP2D6—Biological oxidations—CYP3A4—bone cancer	7.6e-05	0.000899	CbGpPWpGaD
Fluvastatin—CYP2C9—Biological oxidations—CYP3A4—bone cancer	7.53e-05	0.000892	CbGpPWpGaD
Fluvastatin—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	7.49e-05	0.000887	CbGpPWpGaD
Fluvastatin—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	7.43e-05	0.000879	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	7.38e-05	0.000874	CbGpPWpGaD
Fluvastatin—CYP2C19—Biological oxidations—GSTP1—bone cancer	7.06e-05	0.000836	CbGpPWpGaD
Fluvastatin—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	6.97e-05	0.000825	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—ENO2—bone cancer	6.79e-05	0.000804	CbGpPWpGaD
Fluvastatin—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	6.56e-05	0.000776	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—NDUFA12—bone cancer	6.55e-05	0.000776	CbGpPWpGaD
Fluvastatin—CYP2D6—Biological oxidations—GSTP1—bone cancer	6.5e-05	0.000769	CbGpPWpGaD
Fluvastatin—CYP2C9—Biological oxidations—GSTP1—bone cancer	6.44e-05	0.000763	CbGpPWpGaD
Fluvastatin—CYP1A2—Biological oxidations—CYP3A4—bone cancer	6.44e-05	0.000762	CbGpPWpGaD
Fluvastatin—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	6.41e-05	0.000759	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—NDUFA12—bone cancer	6.4e-05	0.000758	CbGpPWpGaD
Fluvastatin—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	6.35e-05	0.000752	CbGpPWpGaD
Fluvastatin—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	6.35e-05	0.000751	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—DHFR—bone cancer	6.3e-05	0.000746	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—NDUFA12—bone cancer	6.05e-05	0.000716	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—GNA11—bone cancer	5.89e-05	0.000697	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	5.81e-05	0.000687	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	5.81e-05	0.000687	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—NDUFA12—bone cancer	5.55e-05	0.000657	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—ENO2—bone cancer	5.53e-05	0.000655	CbGpPWpGaD
Fluvastatin—CYP1A2—Biological oxidations—GSTP1—bone cancer	5.5e-05	0.000652	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—NT5C3A—bone cancer	5.43e-05	0.000643	CbGpPWpGaD
Fluvastatin—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	5.43e-05	0.000643	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—CYP3A4—bone cancer	5.34e-05	0.000632	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.31e-05	0.000629	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—NT5C3A—bone cancer	5.31e-05	0.000628	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—ENO2—bone cancer	5.21e-05	0.000617	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—DHFR—bone cancer	5.13e-05	0.000608	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—NT5C3A—bone cancer	5.01e-05	0.000594	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—NDUFA12—bone cancer	4.95e-05	0.000586	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—DHFR—bone cancer	4.84e-05	0.000573	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—GNA11—bone cancer	4.8e-05	0.000568	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—ENO2—bone cancer	4.7e-05	0.000557	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—NT5C3A—bone cancer	4.6e-05	0.000544	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—GSTP1—bone cancer	4.56e-05	0.00054	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—NDUFA12—bone cancer	4.55e-05	0.000539	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—GNA11—bone cancer	4.52e-05	0.000535	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—NDUFA12—bone cancer	4.51e-05	0.000534	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—DHFR—bone cancer	4.36e-05	0.000517	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—CYP3A4—bone cancer	4.35e-05	0.000515	CbGpPWpGaD
Fluvastatin—CYP3A4—Biological oxidations—GSTP1—bone cancer	4.25e-05	0.000503	CbGpPWpGaD
Fluvastatin—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	4.19e-05	0.000496	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—NT5C3A—bone cancer	4.1e-05	0.000486	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—CYP3A4—bone cancer	4.1e-05	0.000485	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—GNA11—bone cancer	4.08e-05	0.000483	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	4.08e-05	0.000483	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—NDUFA12—bone cancer	3.86e-05	0.000457	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—ENO2—bone cancer	3.82e-05	0.000453	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—NT5C3A—bone cancer	3.77e-05	0.000447	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—NT5C3A—bone cancer	3.74e-05	0.000443	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—GSTP1—bone cancer	3.72e-05	0.00044	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—CYP3A4—bone cancer	3.7e-05	0.000438	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—DHFR—bone cancer	3.55e-05	0.00042	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—GSTP1—bone cancer	3.51e-05	0.000415	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—ENO2—bone cancer	3.5e-05	0.000415	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—GNA11—bone cancer	3.31e-05	0.000392	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—DHFR—bone cancer	3.25e-05	0.000385	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—NT5C3A—bone cancer	3.2e-05	0.000378	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—GSTP1—bone cancer	3.16e-05	0.000374	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—GNA11—bone cancer	3.04e-05	0.00036	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—CYP3A4—bone cancer	3.01e-05	0.000356	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—NDUFA12—bone cancer	2.98e-05	0.000352	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—CYP3A4—bone cancer	2.75e-05	0.000326	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.74e-05	0.000324	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—GSTP1—bone cancer	2.57e-05	0.000304	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—NT5C3A—bone cancer	2.47e-05	0.000292	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—ENO2—bone cancer	2.38e-05	0.000282	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—PTGS2—bone cancer	2.36e-05	0.00028	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—GSTP1—bone cancer	2.36e-05	0.000279	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—ENO2—bone cancer	2.32e-05	0.000275	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—DHFR—bone cancer	2.21e-05	0.000261	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—ENO2—bone cancer	2.2e-05	0.00026	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—DHFR—bone cancer	2.16e-05	0.000255	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—GNA11—bone cancer	2.06e-05	0.000244	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—DHFR—bone cancer	2.04e-05	0.000241	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—GNA11—bone cancer	2.02e-05	0.000239	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—ENO2—bone cancer	2.01e-05	0.000238	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—PTGS2—bone cancer	1.93e-05	0.000228	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—GNA11—bone cancer	1.9e-05	0.000225	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—CYP3A4—bone cancer	1.87e-05	0.000221	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—DHFR—bone cancer	1.87e-05	0.000221	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—CYP3A4—bone cancer	1.83e-05	0.000216	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PTGS2—bone cancer	1.82e-05	0.000215	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—ENO2—bone cancer	1.8e-05	0.000213	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—GNA11—bone cancer	1.75e-05	0.000207	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—CYP3A4—bone cancer	1.73e-05	0.000204	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.72e-05	0.000203	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—DHFR—bone cancer	1.67e-05	0.000197	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—ENO2—bone cancer	1.65e-05	0.000196	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PTGS2—bone cancer	1.64e-05	0.000194	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—ENO2—bone cancer	1.64e-05	0.000194	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—GSTP1—bone cancer	1.6e-05	0.000189	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CYP3A4—bone cancer	1.58e-05	0.000187	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.57e-05	0.000186	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—GSTP1—bone cancer	1.56e-05	0.000185	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—GNA11—bone cancer	1.56e-05	0.000184	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—DHFR—bone cancer	1.53e-05	0.000182	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—DHFR—bone cancer	1.52e-05	0.00018	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—GSTP1—bone cancer	1.48e-05	0.000175	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—GNA11—bone cancer	1.43e-05	0.00017	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—GNA11—bone cancer	1.42e-05	0.000168	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CYP3A4—bone cancer	1.41e-05	0.000167	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.41e-05	0.000166	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ENO2—bone cancer	1.4e-05	0.000166	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—GSTP1—bone cancer	1.35e-05	0.00016	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PTGS2—bone cancer	1.33e-05	0.000158	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CYP3A4—bone cancer	1.3e-05	0.000154	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—DHFR—bone cancer	1.3e-05	0.000154	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CYP3A4—bone cancer	1.29e-05	0.000152	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.28e-05	0.000152	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PTGS2—bone cancer	1.22e-05	0.000144	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GNA11—bone cancer	1.21e-05	0.000144	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—GSTP1—bone cancer	1.21e-05	0.000143	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—GSTP1—bone cancer	1.11e-05	0.000132	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—GSTP1—bone cancer	1.1e-05	0.00013	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CYP3A4—bone cancer	1.1e-05	0.00013	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.09e-05	0.00013	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ENO2—bone cancer	1.08e-05	0.000128	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—DHFR—bone cancer	1e-05	0.000119	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GSTP1—bone cancer	9.41e-06	0.000111	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GNA11—bone cancer	9.37e-06	0.000111	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PTGS2—bone cancer	8.28e-06	9.81e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PTGS2—bone cancer	8.1e-06	9.58e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PTGS2—bone cancer	7.65e-06	9.05e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTP1—bone cancer	7.26e-06	8.6e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PTGS2—bone cancer	7.01e-06	8.3e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PTGS2—bone cancer	6.26e-06	7.41e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PTGS2—bone cancer	5.76e-06	6.82e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PTGS2—bone cancer	5.71e-06	6.76e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PTGS2—bone cancer	4.88e-06	5.77e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PTGS2—bone cancer	3.76e-06	4.46e-05	CbGpPWpGaD
